Guess which ASX 100 share is sinking despite record results

This healthcare stock had a record half. Here's what drove its growth.

| More on:
A woman with bright yellow hair wearing a brightly patterned blouse reacts to big news that she's reading on her phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) shares are falling on Thursday morning.

At the time of writing, the ASX 100 stock is down almost 5% to $32.97.

This follows the release of the medical device company's half year results.

ASX 100 stock falls on results day

  • Operating revenue up 18% to a record of NZ$951.2 million
  • Gross margin improved to 61.9%
  • Net profit after tax up 43% to NZ$153.2 million
  • Interim dividend up 3% to 18.5 NZ cents per share
  • Investment in R&D was 12% of revenue or NZ$110.1 million

What happened during the half?

For the six months ended 30 September, Fisher & Paykel Healthcare reported an 18% increase in operating revenue to a record of NZ$951.2 million.

This was driven by strong top line growth from both its Hospital and Homecare segments.

Hospital operating revenue, which includes humidification products used in respiratory, acute and surgical care, increased 21% to approximately NZ$591.4 million for the half. Hospital new applications consumables revenue increased 24% in constant currency.

Whereas Homecare operating revenue increased 14% to approximately NZ$359.4 million. Sales of masks and accessories for treating obstructive sleep apnea (OSA) were up 14% in constant currency.

The ASX 100 stock's gross margin improved markedly during the half to 61.9%. This represents a 141 basis-point increase in reported currency over the prior comparable period or a 198 basis-point increase in constant currency.

This ultimately led to Fisher & Paykel Healthcare posting a 43% increase in net profit after tax to NZ$153.2 million for the half.

Commenting on the half, the company's CEO, Lewis Gradon, said:

This result was driven primarily by new product introductions and changing clinical practice. Early indications are that a relatively high hospital census during the period may have contributed as well, as hospitals returned to more normalised staffing and capacity, and seasonal hospitalisations in the Northern Hemisphere from FY24 persisted into the beginning of our current financial year.

Growth has been broad-based across our entire portfolio of hospital products, including in invasive and noninvasive ventilation and Optiflow for respiratory and anesthesia patients, all suggesting that we are making headway with changing clinical practice. We are also pleased with the continued strong performance of our range of masks for patients with obstructive sleep apnea.

Outlook

Despite the strong half, the ASX 100 stock has only held firm with its guidance for the full year.

It has reiterated its guidance for revenue of NZ$1.9 billion to NZ$2 billion and net profit after tax of approximately NZ$320 million to NZ$370 million.

It seems that the market was hoping that the company would increase its guidance this morning.

Should you invest $1,000 in Fisher & Paykel Healthcare Corporation Limited right now?

Before you buy Fisher & Paykel Healthcare Corporation Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Fisher & Paykel Healthcare Corporation Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 7 February 2025

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A man in shirt and tie uses his mobile phone under water.
Share Market News

2 ASX 200 shares sinking on Thursday on earnings results

Investors are bidding down these ASX 200 shares today. But why?

Read more »

Man pointing at a blue rising share price graph.
Earnings Results

2 ASX 300 shares rocketing 6% today

Investors love what these two stocks just reported.

Read more »

A man raises his reading glasses in a look of surprise.
Earnings Results

South32 share price higher on 577% profit jump

This mining giant's profits have surged during the first half.

Read more »

A couple lying down and laughing, symbolising passive income.
Earnings Results

Temple & Webster share price jumps 17% to record high on stunning half-year results

It was another impressive six months for this high flying stock.

Read more »

smiling worker stands before power generator technology
Earnings Results

Origin Energy share price charging higher on growing profits

Origin Energy shares are racing ahead of the benchmark on Thursday.

Read more »

Gold bars and Australian dollar notes.
Earnings Results

Northern Star share price lifts off on record half-year dividend

Up 39% in a year, ASX investors are bidding up Northern Star shares again on Thursday.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Earnings Results

Pro Medicus share price storms higher on record-breaking results

Investors are cheering on this tech company's latest results.

Read more »

CA woman sits on her bed wailing and crying with a wine bottle in one hand and a glass in the other.
Earnings Results

Treasury Wine share price sinks 7% on weak FY25 guidance

The Penfolds owner has released its half year results. What did it report?

Read more »